Bleakley Financial Group LLC Acquires 76 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)

Bleakley Financial Group LLC increased its holdings in West Pharmaceutical Services, Inc. (NYSE:WST) by 3.3% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 2,358 shares of the medical instruments supplier’s stock after purchasing an additional 76 shares during the period. Bleakley Financial Group LLC’s holdings in West Pharmaceutical Services were worth $708,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of WST. Sumitomo Mitsui Trust Holdings Inc. increased its position in shares of West Pharmaceutical Services by 1.5% during the first quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 191,469 shares of the medical instruments supplier’s stock valued at $75,766,000 after buying an additional 2,759 shares during the period. Mizuho Markets Americas LLC boosted its holdings in West Pharmaceutical Services by 142.3% in the 1st quarter. Mizuho Markets Americas LLC now owns 29,628 shares of the medical instruments supplier’s stock valued at $11,724,000 after purchasing an additional 17,399 shares during the period. AMI Asset Management Corp grew its position in shares of West Pharmaceutical Services by 3.3% during the 1st quarter. AMI Asset Management Corp now owns 164,738 shares of the medical instruments supplier’s stock valued at $65,188,000 after purchasing an additional 5,217 shares in the last quarter. Tidal Investments LLC increased its holdings in shares of West Pharmaceutical Services by 54.7% in the first quarter. Tidal Investments LLC now owns 10,574 shares of the medical instruments supplier’s stock worth $4,181,000 after purchasing an additional 3,738 shares during the period. Finally, SG Americas Securities LLC raised its position in shares of West Pharmaceutical Services by 44.4% in the first quarter. SG Americas Securities LLC now owns 12,365 shares of the medical instruments supplier’s stock worth $4,893,000 after buying an additional 3,802 shares in the last quarter. 93.90% of the stock is currently owned by hedge funds and other institutional investors.

West Pharmaceutical Services Price Performance

NYSE:WST opened at $287.25 on Tuesday. The firm has a market capitalization of $20.84 billion, a price-to-earnings ratio of 40.86, a P/E/G ratio of 10.46 and a beta of 1.01. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.68 and a current ratio of 2.34. The stock has a fifty day moving average of $299.96 and a 200 day moving average of $324.52. West Pharmaceutical Services, Inc. has a 52-week low of $265.00 and a 52-week high of $413.70.

West Pharmaceutical Services (NYSE:WST) last issued its quarterly earnings data on Thursday, July 25th. The medical instruments supplier reported $1.52 EPS for the quarter, missing the consensus estimate of $1.74 by ($0.22). The business had revenue of $702.10 million for the quarter, compared to analysts’ expectations of $729.36 million. West Pharmaceutical Services had a return on equity of 19.17% and a net margin of 18.25%. The firm’s revenue for the quarter was down 6.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.11 EPS. On average, research analysts expect that West Pharmaceutical Services, Inc. will post 6.42 EPS for the current fiscal year.

Insider Transactions at West Pharmaceutical Services

In related news, VP Charles Witherspoon sold 1,029 shares of the company’s stock in a transaction on Monday, August 19th. The shares were sold at an average price of $300.00, for a total value of $308,700.00. Following the completion of the transaction, the vice president now directly owns 1,478 shares in the company, valued at approximately $443,400. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.53% of the company’s stock.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.